Active Ingredient (In Each Extended-Release Tablet)
Guaifenesin 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rugby Laboratories for the product Rugby Mucus Relief Er (NDC 0536-1451). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each extended-release tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 1200 mg
Expectorant
These could be signs of a serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, copovidone, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium starch glycolate
1-800-719-9260
Rugby®
compare to Maximum Strength Mucinex® active ingredient
maximum strength
mucus relief ER
guaifenesin extended-release tablets, 1200 mg
expectorant
12 hour
• relieves chest congestion
• thins and loosens mucus
• immediate and extended release
14 extended-release tablets
actual size
* Please review the disclaimer below.